PHF5A assessment as a potential biomarker and splicing component attains advanced consideration for a) determination of its structural, biological, and functional attributes b) analysis of mutation sites, and c) determination of underlying molecular mechanism responsible for tumor propagation and progression for designing of site-specific therapeutic moieties. This evidence concerns the gene PHF5A and neoplasm.